InvestorsHub Logo

Parapraxis

06/24/16 10:16 PM

#43463 RE: rikshot #43462

We were told the R/S was the financing tool.

criticalnugz

06/24/16 11:14 PM

#43464 RE: rikshot #43462

Unfortunately, looks like plans are contingent on generating revenues through existing contracts (which is expected to only bring in 640K for 2016 thru 7 active contracts) and obtaining new business; otherwise, they're going to issue common stock for funds.

In a couple places in the most recent 10k:

As of March 16, 2016, we have seven active contracts with respect to which we expect to perform and generate up to approximately $690,000 in revenues in fiscal 2016, subject to the achievement by us of certain performance milestones, as well as our contracts not being terminated by our clients.



We plan to raise additional funds in the future by issuing additional shares of common stock or other securities, which may include securities such as convertible debentures, warrants or preferred stock that are convertible into common stock.



Accordingly, we will have to obtain additional capital from the sale of additional securities or by borrowing funds from lenders to fulfill our business plans.



I think Sigma Labs is doing what is good for the business, just not the retail shareholders. It would be interesting to see if they would repay shareholders in some fashion for being a shareholder since a specified timeframe if significant revenues are realized.